
Vibcare Pharma
05/10/26
| Company | Location | What it makes | Listed |
|---|---|---|---|
| Ind-Swift Laboratories | HQ Chandigarh | Formulations (sold its API business) | Yes |
| Panacea Biotec | Registered office Lalru | Vaccines | Yes |
| Sun Pharma | Mohali plant (ex-Ranbaxy) | Finished medicines | Yes |
| Cipla | Baddi plants | Tablets, inhalers | Yes |
| Morepen Laboratories | Baddi complex (10 plants) | APIs, formulations | Yes |
| Indoco Remedies | Baddi plants I and II | Tablets, creams, liquids | Yes |
| Zydus Lifesciences | Baddi formulations plant | Formulations | Yes |
| Alkem Laboratories | Baddi facility | Formulations | Yes |
| Glenmark | Baddi API plant | APIs | Yes |
| Vibcare Pharma | Panchkula (office and WHO-GMP plant) | Tablets, capsules, oral liquids, externals; PCD franchise | No |
Pharmaceutical activity around Chandigarh is spread across the tricity of Chandigarh, Panchkula in Haryana and Mohali in Punjab, with a mix of company headquarters, corporate offices, plants and academic institutions. One notable institution is NIPER S.A.S. Nagar (Mohali), a postgraduate pharmaceutical education and research institute established in 1998 as an Institute of National Importance under the Ministry of Chemicals and Fertilizers.
Industry and labour links with the nearby Baddi belt are close. According to a Tribune report from June 2020, about 50% of staff at large pharma units in the Baddi-Barotiwala-Nalagarh belt commute from the tricity, across the state border into Himachal Pradesh.
No official count of pharmaceutical companies exists for Chandigarh, Panchkula or Mohali. Online directories typically list around 140 to 150 entries for each city, but these mix PCD and marketing firms with actual manufacturers, so they should not be read as an official figure. Anyone researching companies in the area should verify licences and addresses with the state drug controller or the company itself.
The Baddi-Barotiwala-Nalagarh industrial area in Solan district of Himachal Pradesh, roughly 40 km from Chandigarh, is the main pharmaceutical manufacturing area of Himachal Pradesh. Invest India, the Government of India's investment promotion body, states that 35% of all medicines manufactured in India come from Himachal Pradesh.
According to Indian Pharma Post (August 2026, citing a Rajya Sabha reply by Minister of State Anupriya Patel), 43 pharma units in Solan district were approved under a central scheme over two financial years: 16 in FY25 and 27 in FY26. A separate Bulk Drug Park at Una in Himachal Pradesh, with an investment of ₹2,071 crore, is expected to create about 20,000 jobs.
The belt has plants of Indian and multinational firms; the companies below alone make APIs, tablets, creams, liquids and inhalers there.
The following companies have a headquarters, registered office or major manufacturing plant in or around Chandigarh, Panchkula, Mohali or the Baddi belt.
Ind-Swift Laboratories is headquartered at SCO 850, NAC Manimajra, Chandigarh. The Ind-Swift group has been active since 1986 and the company was incorporated in 1995. It sold its API and CRAMS business — three sites — to Synthimed Labs for ₹1,650 crore and is now focused on formulations in areas such as gynaecology, paediatrics, cardiology and dermatology. It merged with Ind-Swift Ltd after NCLT approval on 17 July 2025. FY26 revenue was about ₹626 crore. The company is listed on Indian stock exchanges.
Nectar Lifesciences, based around Chandigarh and Derabassi, was once an active pharma manufacturer but sold its pharma units and menthol business to Ceph Lifesciences for ₹1,253.99 crore in November 2025, and changed its objects to real estate and should no longer be counted as a current pharmaceutical maker in the region.
Panacea Biotec has its registered office on the Ambala-Chandigarh Highway at Lalru in Punjab, with a corporate office in New Delhi. Founded in 1984, the company is known for vaccines including EasyFive, EasySix and DengiAll. FY26 revenue was about ₹640 crore. It is listed on Indian stock exchanges.
Sun Pharmaceutical Industries operates a plant at Mohali that it inherited with its acquisition of Ranbaxy. The US FDA lifted the import alert on this plant on 16 March 2017. Sun Pharma is India's largest pharmaceutical company by revenue and is listed on Indian stock exchanges.
Cipla runs manufacturing Units I and II at Baddi, producing oral solid doses and inhalers (metered-dose inhalers and dry powder inhalers). The site underwent a WHO inspection in January and February 2024. Cipla is listed on Indian stock exchanges.
Morepen Laboratories states on its company website that it is headquartered at a Baddi complex of 10 plants, with additional sites at Masulkhana and Parwanoo. Its products include active pharmaceutical ingredients such as loratadine, atorvastatin and montelukast. FY26 revenue was about ₹1,806 crore. It is listed on Indian stock exchanges.
Indoco Remedies has two plants at Baddi — Plant I and Plant II. Plant I manufactures tablets, creams, ointments, liquids and toothpaste. The company is listed on Indian stock exchanges.
Zydus Lifesciences operates a formulations plant at Baddi. The US FDA issued an Establishment Inspection Report with a 'no action indicated' outcome for this facility in November 2019. The company is listed on Indian stock exchanges.
Alkem Laboratories has a manufacturing facility at Baddi. In August 2026, its board approved an investment of up to ₹75 crore for a new block at the Baddi facility, indicating continued expansion in the region. The company is listed on Indian stock exchanges.
Glenmark Pharmaceuticals has an active pharmaceutical ingredient (API) plant at Baddi. The company is listed on Indian stock exchanges.
Vibcare Pharma Pvt Ltd is a Panchkula-based pharmaceutical company with its corporate office at Plot No 4, HSIIDC IT Park, Sector 22, Panchkula, Haryana 134109. Incorporated in 2014, it began commercial operations in 2015 and appoints PCD pharma franchise partners district by district — one partner per district, with monopoly rights confirmed in writing. The company currently works with more than 5,000 franchise partners and offers products across 11 divisions.
Manufacturing is carried out by Vibcare Healthcare, which owns a WHO-GMP plant at Khasra 6/2/2, Kot Road, Village Dabkori, Panchkula 134103. The WHO-GMP site certificate (No. 1/182-1Drug-I-2024) was issued by the State Drugs Controller, FDA Haryana, on 24 October 2024, and GMP compliance under the revised Schedule M was certified on 14 November 2024. The plant occupies 1 lakh square feet on five acres. Its stated annual capacity is 1.1 billion tablets, 950 million capsules, 30 million bottles of oral liquids and 40 million tubes of external preparations.
Injectables, ophthalmics and the NURALZ ayurvedic range are produced at partner WHO-GMP units, with the manufacturer named on each pack. Vibcare also offers third-party manufacturing for other brands.
The Chandigarh tricity and the Baddi belt together offer jobs across manufacturing, quality assurance, regulatory affairs, sales, marketing and distribution. Job seekers can look at company websites and placement cell notices at institutions like NIPER Mohali for openings.
Distributors and entrepreneurs can partner with established companies through PCD pharma franchise models, which typically require a wholesale drug licence and GST registration. Vibcare Pharma, for example, offers district-level PCD franchise rights from Panchkula. Brands that want to outsource production can use third-party manufacturing at WHO-GMP plants in the region.
Ind-Swift Laboratories is headquartered at NAC Manimajra in Chandigarh and is now a formulations-focused company after selling its API business. Nectar Lifesciences, once based around Chandigarh and Derabassi, sold its pharma units in November 2025 and moved into real estate. Several other companies have offices or marketing operations in the city.
Vibcare Pharma Pvt Ltd has its corporate office in HSIIDC IT Park, Sector 22, Panchkula, and its WHO-GMP manufacturing plant at Village Dabkori, Panchkula. The company runs a PCD pharma franchise and third-party manufacturing business. Other marketing and distribution firms also operate from Panchkula, and many more have plants in the Baddi belt next door.
Baddi is called a pharma hub because it hosts a large concentration of pharmaceutical manufacturing units in the Baddi-Barotiwala-Nalagarh belt in Solan district, Himachal Pradesh. According to Invest India, 35% of all medicines manufactured in India come from Himachal Pradesh. Many large Indian companies, including Cipla, Zydus, Alkem, Glenmark, Indoco and Morepen, have plants there.
Baddi is about 40 km from Chandigarh. The Baddi-Barotiwala-Nalagarh belt lies just across the Himachal Pradesh border from the tricity, and about half of the staff at large pharma units there commute from Chandigarh, Panchkula or Mohali, according to a Tribune report from 2020.
There is no official count of pharmaceutical companies for Chandigarh, Panchkula or Mohali. Online directories typically list around 140 to 150 entries per city, but these include PCD and marketing firms as well as manufacturers. For an accurate picture, check with the state drug controller or the companies directly.
To start a PCD pharma franchise, you generally need a wholesale drug licence and GST registration. Companies like Vibcare Pharma then appoint franchise partners district by district, giving one partner per district with monopoly rights confirmed in writing. Contact the company directly to learn about available districts, product ranges and terms.
Partner with a Panchkula pharma company
Vibcare appoints one PCD franchise partner per district, with monopoly rights confirmed in writing. Third-party manufacturing is also available at WHO-GMP plants.
Copy Link